Association of PKCζ Expression with Clinicopathological Characteristics of Breast Cancer

Jian Yin; Zhipei Liu; Haixin Li; Jingyan Sun; Xinzhong Chang; Jing Liu; Shanshan He; Binghui Li

doi:10.1371/journal.pone.0090811

Loading metrics

Open Access

Peer-reviewed

Research Article

Association of PKCζ Expression with Clinicopathological Characteristics of Breast Cancer

Jian Yin ,

* E-mail: yinjian@tjmuch.com

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China
⨯
Zhipei Liu,

Affiliations Production and R&D Center, Tianjin Binhai Union Gene Technology Co. LTD, Tianjin, China, Gene Bank, Union Stem Cell & Gene Engineering Co. LTD, Tianjin, China
⨯
Haixin Li,

Affiliation Tumor Tissue Banking Facility, Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⨯
Jingyan Sun,

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China
⨯
Xinzhong Chang,

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China
⨯
Jing Liu,

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China
⨯
Shanshan He,

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China
⨯
Binghui Li

Affiliation Laboratory of Cancer Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⨯

Association of PKCζ Expression with Clinicopathological Characteristics of Breast Cancer

Jian Yin,
Zhipei Liu,
Haixin Li,
Jingyan Sun,
Xinzhong Chang,
Jing Liu,
Shanshan He,
Binghui Li

Published: March 6, 2014
https://doi.org/10.1371/journal.pone.0090811

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Carcinoma
Is the Subject Area "Carcinoma" applicable to this article?

Thanks for your feedback.
Invasive ductal carcinoma
Is the Subject Area "Invasive ductal carcinoma" applicable to this article?

Thanks for your feedback.
Lymph nodes
Is the Subject Area "Lymph nodes" applicable to this article?

Thanks for your feedback.
Invasive tumors
Is the Subject Area "Invasive tumors" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.